SRx Health Solutions, Inc. reported the sale of up to $30.46 million in new Series A convertible preferred stock and warrants on October 27, 2025, with initial proceeds of approximately $15.23 million from the first closing on October 31, 2025.
AI Assistant
SRX HEALTH SOLUTIONS INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.